DYHYDROMATICS EUROPE
Contact: Markus Vielsack
Tel: +49-7231-674-048
E-mail: mvielsack@godyhydro.com
Country: Germany
DYHYDROMATICS INDIA
Contact: Nitin Rashinkar
Tel: +91-77381-42553
E-mail: nrashinkar@godyhydro.com
Country: India
ADEIRA PHARMCEUTICALS
Adeira Pharma is at the intersection of nanotechnology and drug formulation, offering BioPharma clients a suite of proprietary and robust lipid nanoparticle systems to meet the challenges of formulating new therapeutics. The remarkable stability of the nanoparticle platform against a wide range of temperature and pH allows for an extensive variety of post-formulation modifications to decorate the nanoparticles with targeting and therapeutic ligands, and many other surface modifications. From improving the performance and extending the patent life of existing drugs to addressing the most difficult formulation challenges, Adeira’s technology platform offers extremely adaptable drug delivery systems that employ only excipients with extensive safety histories of in-human uses.
Contact: Kendall Killgore
Address: 20 S. Sarah Street St Louis, MO 63108
Tel: 314-606-7265
E-mail: kkillgore@adeirapharma.com
Country: USA
FINA BIO SOLUTIONS
Fina Biosolutions provides laboratory services, conjugation technology, and consulting in the field of conjugate vaccines and conjugation chemistry. FinaBio was founded in 2006 by Dr. Andrew Lees, who developed the conjugation chemistry used by GlaxoSmithKline and the Serum Institute of India in their pneumococcal and meningococcal vaccines. Dr. Lees is the inventor on over 25 patents with 75 peer-reviewed publications. Conjugate vaccines, in which an antigen is chemically linked to a protein “carrier,” are among the most complex and expensive of the childhood vaccines. FinaBio is committed to increasing the availability of carrier proteins and conjugation technology with the goal of promoting vaccine research and affordable vaccines.
Conjugation Services: FinaBio performs conjugation covering diverse antigens, carrier proteins, and chemistry. Antigens have included peptides, oligosaccharides (both synthetic and natural), polysaccharides, chemical haptens, and proteins. Chemistries span reductive amination, CDAP, thiol-ether, click, and others. Our facility is well-equipped for conjugate synthesis and characterization. In addition to contract conjugation, we develop conjugation protocols, train client scientists, and assist with technology transfer and implementation.
Carrier proteins: Our carrier protein portfolio includes CRM197 and 8MTT, genetically detoxified diphtheria and tetanus toxin, respectively, and the Qb virus-like-particle. Our CRM197, which we market as EcoCRM®, is available for both research and GMP grades. We are the only provider of full-length genetically detoxified tetanus toxin. We also offer our carrier proteins in a pre-labeled, ready-to-conjugate format to simplify conjugate synthesis. The newest addition to our portfolio is site-specific ClickCRM.
Contact: Andrew Lee
Tel: 301-633-0464
E-mail: alees@finabio.com
Address: 9430 Key W Ave, Rockville, MD 20850
Country: USA
DELPHI SCIENTIFIC:
Delphi Scientific, LLC provides novel solutions to the development and production of nanotechnology based drug delivery systems, from the lab to the clinic. Delphi’s solutions extend across formulation types, indications and dosage forms, including: Lipid nanoparticles, nanoemulsions, liposomes, RNA/DNA formulations, polymers and nanocrystals; vaccines, cancer, brain disease, ocular drugs and anesthetics; injectables, inhalables, ocular and oral formulations.
Delphi Scientific, LLC uses a unique combination of great experience with well known approved drug products, patented technologies and close collaborations with CDMOs, instrumentation and equipment manufacturers around the world.
Contact: Dr. Mimi Panagiotou
Tel: 1-617-669-5910
E-mail: mpanagiotou@delphisci.com
Address: 63 Great Rd suite 109 Maynard, MA 01754
Country: USA